comparemela.com
Home
Live Updates
About Actinium Pharmaceuticals - Breaking News
Pages:
Latest Breaking News On - About actinium pharmaceuticals - Page 2 : comparemela.com
Actinium Announces Positive Top-line Results from Pivotal Phase 3 SIERRA Trial of Iomab-B in Patients with Active Relapsed or Refractory Acute Myeloid Leukemia
/PRNewswire/ Actinium Pharmaceuticals, Inc. (NYSE AMERICAN: ATNM) (Actinium or the Company), a leader in the development of targeted radiotherapies, today.
United states
Hans vitzthum
Lifesci advisors
International blood marrow transplant research
American society of hematology
Astellas pharma inc
Actinium pharmaceuticals inc
Oncology inc
Epicentrx inc
Society of hematologic oncology
Memorial sloan kettering cancer center
Fred hutchinson cancer research center
Actinium pharmaceuticals
Elderly relapsed
Bone marrow transplant
About iomab b
vimarsana © 2020. All Rights Reserved.